Full Download Book Immunology 9Th Edition PDF
Full Download Book Immunology 9Th Edition PDF
Full Download Book Immunology 9Th Edition PDF
IMMUNOLOGY
David Male, BA, MA, PhD
Professor of Biology
Department of Life Sciences
The Open University
Milton Keynes, United Kingdom
The right of David Male, R. Stokes Peebles, Jr., and Victoria Male to be identified as authors of this work has been
asserted by them in accordance with the Copyright, Designs and Patents Act 1988.
No part of this publication may be reproduced or transmitted in any form or by any means, electronic or
mechanical, including photocopying, recording, or any information storage and retrieval system, without
permission in writing from the publisher. Details on how to seek permission, further information about the
Publisher’s permissions policies and our arrangements with organizations such as the Copyright Clearance
Center and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by the Publisher
(other than as may be noted herein).
Notices
Practitioners and researchers must always rely on their own experience and knowledge in evaluating
and using any information, methods, compounds or experiments described herein. Because of rapid
advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages
should be made. To the fullest extent of the law, no responsibility is assumed by Elsevier, authors, editors or
contributors for any injury and/or damage to persons or property as a matter of products liability, negligence
or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in
the material herein.
Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this
publication does not constitute a guarantee or endorsement of the quality or the value of such product or
the claims made of it by its manufacturer.
ISBN: 978-0-7020-7844-6
International ISBN: 978-0-7020-7845-3
Printed in Poland
This is the first edition of Immunology that has not included two elements that we consider essential for understanding basic
of our original editors, Ivan Roitt and Jonathan Brostoff. We and clinical immunology; the online version includes additional
would like to pay tribute to their foresight in developing this information at appropriate points (indicated by a symbol in
text, which was originally planned as a slide atlas of immuno- the margin), for readers who want to delve deeper. The critical
logy. They have steered the book through its eight previous edi- thinking sections that follow each chapter require an under-
tions, during which time the subject has advanced beyond all standing of the material presented and the implications in a lab-
recognition. In 1985 when the first edition was published, the oratory or clinical setting—they may be used as the basis of class
structure and function of antibodies were well known and discussion. Another important teaching tool is the summaries
MHC molecules had just been described, but how T cells which distil the key points of each chapter and are a solid basis
became activated was still a matter of conjecture and debate. for revision for exams.
Nowadays, antibodies have become key therapeutic agents, The contributors to this edition include many experts in dif-
not just for immunological conditions, but particularly for treat- ferent fields of immunology, with seven new contributors who
ment of cancer and the targeting of therapeutic agents. Cytokine- have brought their own expertise to individual chapters. We also
based treatments for many diseases are following closely behind. greatly appreciate the hard work of colleagues at Elsevier, par-
Hence, the subject of immunology impinges on diverse areas ticularly Trinity Hutton, Alex Mortimer and Karthikeyan
of clinical practice, as well as providing tools and important Murthy.
theoretical concepts for many of the biological sciences. Immunology bridges basic science and medicine and encom-
For this edition, and with two new editors, we have made passes genetics, cell biology and molecular biology. Advances in
a major reorganisation in the first half of the book, with innate biotechnology in the last 10 years have driven forward antibody-
immunity and cell-mediated immunity introduced first. based therapies. In the next 10 years we anticipate that under-
This rearrangement responds to our improved understanding standing of genetic diversity in the immune system will lead to
of these areas of immunology, and it also presents material advances in personalised medicine, while gene therapies are
in a more logical chronological order, since innate immune reac- becoming available to correct primary immunodeficiencies.
tions and lymphocyte activation precede antibody production. For the past century, immunology has fascinated and inspired
Despite these changes we have maintained the overall bal- some of the greatest scientific thinkers and Nobel prize winners.
ance of the text with the first two sections describing how the Most recently the prize for Medicine or Physiology was awarded
immune system works. Section three is concerned with immune to James Allison and Tasuko Honjo for advances in cancer
responses against pathogens—the primary function of the immunotherapy. We wish our readers well in their study of
immune system—and the final three sections deal with aspects immunology, a subject that continues to excite and surprise
of clinical immunology, including autoimmune disease, immu- us, and which underpins many areas of medicine and biomed-
nodeficiency, transplantation, tumour immunology and hyper- ical science.
sensitivity. All chapters have been fully updated with many new David Male
diagrams. R. Stokes Peebles, Jr.
We have followed the style of the 8th edition by including two Victoria Male
levels of detail in the text. The printed text includes those 2019
vii
CONTRIBUTORS
The editors would like to acknowledge and offer grateful thanks for the input of all previous editions’ contributors, without whom this
new edition would not have been possible.
Gregory J. Bancroft, BSc Hons, PhD David Isenberg, MD, FRCP, FAMS Luisa Martinez-Pomares, BSc, PhD
Professor Professor Associate Professor
Department of Infection Biology The Centre for Rheumatology Research, School of Life Sciences
Faculty of Infectious and Tropical Diseases Department of Medicine University of Nottingham
London School of Hygiene & Tropical University College London Nottingham, United Kingdom
Medicine London, United Kingdom
London, United Kingdom
Bryan Paul Morgan, BSc, MBBCh, PhD,
Roy Jefferis, BSc, PhD, FRSC, CChem, FRCPath, MRCP
David Bending, BA, MA, PhD
MRCP, FRCPath, DSc Professor of Immunology
Institute of Immunology and
Emeritus Professor School of Medicine
Immunotherapy
Institute of Immunology & Immunotherapy Cardiff University
University of Birmingham
University of Birmingham Cardiff, United Kingdom
Birmingham, United Kingdom
Birmingham, United Kingdom
Persephone Borrow, BA, MA, PhD
Professor of Viral Immunology Thomas Kamradt, Dr. med. Luigi D. Notarangelo, MD
Nuffield Department of Clinical Medicine Professor Chief
University of Oxford Department of Immunology Laboratory of Clinical Immunology
Oxford, United Kingdom University Hospital Jena and Microbiology
Jena, Germany National Institute of Allergy and
Colin Casimir, BSc, PhD Infectious Diseases, National
Department of Natural Sciences Institutes of Health
Middlesex University Yasmin Khan, MD Bethesda, Maryland, United States
London, United Kingdom Assistant Professor of Pediatrics
Department of Pediatric Allergy,
Daniel Cook, MD, PhD Immunology, and Pulmonary Medicine R. Stokes Peebles, Jr., MD
Resident Physician Vanderbilt University Medical Center Elizabeth and John Murray
Department of Internal Medicine Nashville, Tennessee, United States Professor of Medicine
Vanderbilt University Medical Center Division of Allergy, Pulmonary,
Nashville, Tennessee, United States and Critical Care Medicine
Peter Maldwyn Lydyard, BSc, MSc, PhD, Vanderbilt University School of Medicine
FRCPath Nashville, Tennessee, United States
David P. D’Cruz, MD, FRCP Emeritus Professor
Consultant Rheumatologist University College London
The Louise Coote Lupus Unit Visiting Professor
Guy’s and St Thomas’ Hospitals Thomas A.E. Platts-Mills, MD,
University of Westminster PhD, FRS
London, United Kingdom London, United Kingdom Head, Asthma and Allergic Disease Center
Daniel Dulek, MD Department of Medicine
Assistant Professor Arti Mahto, BSc, MBBCh, MRCP, PhD University of Virginia
Department of Pediatric Infectious Diseases Department of Rheumatology Charlottesville, Virginia, United States
Vanderbilt University Medical Center University College Hospital,
Nashville, Tennessee, United States London, United Kingdom
Richard John Pleass, BSc, MSc, PhD
Professor
Hakimeh Ebrahimi-Nik, Doctorate of
David Male, BA, MA, PhD Department of Parasitology
Veterinary Medicine, PhD
Professor of Biology Liverpool School of Tropical Medicine
Postdoctoral Fellow
Department of Life Sciences Liverpool, Merseyside, United Kingdom
Department of Immunology
The Open University
UConn Health
Milton Keynes, United Kingdom
Farmington, Connecticut, United States
Nina Porakishvili, BSc, MSc, PhD
School of Life Sciences
Andrew George, MBE, MA, PhD, DSc, Victoria Male, BA, MA, PhD
University of Westminster
FRCPath, FHEA, FRSA, FRSB Sir Henry Dale Fellow
London, United Kingdom
Emeritus Professor Department of Metabolism
Brunel University London Digestion and Reproduction
Uxbridge, United Kingdom Imperial College London
London, United Kingdom
ix
x CONTRIBUTORS
Theo Rispens, PhD Pramod K. Srivastava, PhD, MD Gestur Vidarsson, BSc, MSc, PhD
Department of Immunopathology Professor of Immunology and Medicine Head of Laboratory
Sanquin Research, Amsterdam Director, Carole and Ray Neag Department of Experimental
Amsterdam, Netherlands Comprehensive Cancer Center and Immunohematology/Immunoglobulin
Department of Immunology Research Laboratory
University of Connecticut School of Medicine Sanquin Research
Farmington, Connecticut, United States Amsterdam, Netherlands
SECTION 1 The Immune System and Innate Immunity
1
Introduction to the Immune System
SUMMARY
• The immune system has evolved to protect us from pathogens. Intra- • Antigens are molecules that are recognized by receptors on B cells
cellular pathogens infect individual cells (e.g. viruses), whereas extracellular and T cells. B cells usually recognize intact antigen molecules, whereas T
pathogens divide outside cells in blood, tissues or the body cavities (e.g. many cells recognize antigen fragments displayed on the surface of the body’s
bacteria and parasites). These two kinds of pathogen require fundamentally own cells.
different immune responses. • An immune response occurs in two phases – antigen recognition and
• Phagocytes and lymphocytes are key mediators of immunity. Phago- antigen eradication. In the first phase, clonal selection involves recognition
cytes internalize pathogens and degrade them. Lymphocytes (B and T cells) of antigen by particular clones of lymphocytes, leading to expansion of specific
have receptors that recognize specific molecular components of pathogens clones of T and B cells and differentiation to effector and memory cells. In the
and have specialized functions. B cells make antibodies (effective against effector phase, these lymphocytes coordinate an immune response, which
extracellular pathogens), cytotoxic T lymphocytes (CTLs) kill virally infected eliminates the source of the antigen.
cells and helper T cells coordinate the immune response by direct cell–cell • Vaccination depends on the specificity and memory of adaptive
interactions and the release of cytokines. immunity. Vaccination is based on the key elements of adaptive immunity,
• Inflammation is a response to tissue damage. It allows antibodies, com- namely specificity and memory. Memory cells allow the immune system to
plement system molecules and leukocytes to enter the tissue at the site of mount a much stronger and more rapid response on a second encounter with
infection, resulting in phagocytosis and destruction of the pathogens. Lympho- antigen.
cytes are also required to recognize and to destroy infected cells in the tissues. • The immune system may fail (immunopathology). This can be a result of
• Specificity and memory are two essential features of adaptive immunodeficiency, hypersensitivity or dysregulation leading to autoimmune
immune responses. As a result, the adaptive arm of the immune system diseases.
(B and T lymphocytes) mounts a more effective response on second and sub- • Normal immune reactions can be inconvenient in modern medicine,
sequent encounters with a particular antigen. Non-adaptive (innate) immune for example blood transfusion reactions and graft rejection.
responses (mediated, for example, by complement and phagocytes) do not
alter on repeated exposure to an infectious agent.
The immune system is fundamental to survival, as it protects • It introduces the basic elements of the immune system and
the body from pathogens: viruses, bacteria and parasites that of immune responses, which are mediated principally by
cause disease. To do so, it has evolved a powerful collection white blood cells or leukocytes (from the Greek for white
of defence mechanisms to recognize and protect against poten- cell) and are detailed in Chapters 2–13.
tial invaders that would otherwise take advantage of the rich Over many millions of years, different types of immune
source of nutrients provided by the vertebrate host. At the same defence, appropriate to the infecting pathogens, have evolved
time it must differentiate between the individual’s own cells and in different groups of organisms. In this book, we concentrate
those of harmful invading organisms while not attacking the on the immune systems of mammals, especially humans.
beneficial commensal flora that inhabit the gut, skin and other Because mammals are warm-blooded and long-lived, their
tissues. immune systems have evolved particularly sophisticated sys-
This chapter provides an overview of the complex network tems for recognizing and destroying pathogens.
of processes that form the immune system of higher Many of the immune defences that have evolved in other
vertebrates: vertebrates (e.g. reptiles, amphibians) and other phyla (e.g.
• It illustrates how the components of the immune system fit sponges, worms, insects) are also present in some form in
together to allow students to grasp the big picture before mammals. Consequently the mammalian immune system con-
delving into the material in more depth in subsequent sists of multi-layered, interlocking defence mechanisms that
chapters. incorporate both ancient and recently evolved elements.
1
2 SECTION 1 The Immune System and Innate Immunity
leukocytes
other
cell lymphocytes phagocytes auxiliary cells
B T ILC
Fig. 1.1 Components of the immune system The principal cells of the immune system and the mediators they
produce are shown. Neutrophils, eosinophils and basophils are collectively known as polymorphonuclear gran-
ulocytes (see Chapter 2). B cells and T cells have highly specific receptors for foreign material (antigens),
whereas innate lymphoid cells (ILCs) do not have the specific receptors. Cytotoxic describes the function of
different cells, including cytotoxic T lymphocytes (CTLs), natural killer (NK) cells (a type of ILC) and eosinophils.
Complement is made primarily by the liver, although there is some synthesis by mononuclear phagocytes. Note
that each cell produces and secretes only a particular set of cytokines or inflammatory mediators.
Treg
antigen antigen
presentation presentation
B
Fig. 1.5 Functions of different types of lymphocyte Macrophages present antigen to TH1 cells, which then
activate the macrophages to destroy phagocytosed pathogens. B cells present antigen to TH2 cells, which acti-
vate the B cells, causing them to divide and differentiate into antibody-secreting plasma cells. TH17 cells help to
protect mucosal surfaces by attracting and activating other leukocytes. Cytotoxic T lymphocytes (CTL) and nat-
ural killer cells (NK) recognize and destroy virally infected cells. Regulatory T cells (Treg) modulate activity of
other T-cell populations.
of immunity towards a site of infection. Inflammation is medi- Complement proteins mediate phagocytosis, control
ated by a variety of other cells, including basophils, mast cells inflammation and interact with antibodies in immune
and platelets. defence. The complement system, a key component of innate
Basophils and mast cells have granules that contain a variety immunity, is a group of about 20 serum proteins whose overall
of mediators, which induce inflammation in surrounding tissues function is to promote inflammation (Fig. 1.6) and clearance of
and are released when the cells are triggered. Basophils and mast microbes and damaged cells. The components interact with
cells can also synthesize and secrete a number of mediators that each other and with other elements of the immune system.
control the development of immune reactions. Mast cells lie For example, a number of microorganisms spontaneously acti-
close to blood vessels in most tissues and some of their media- vate the complement system, via the so-called ‘alternative path-
tors act on cells in the vessel walls. Basophils are functionally way’, which is an innate immune defence. This results in the
similar to mast cells, but are mobile, circulating cells. microorganism being opsonized (i.e. coated by complement
Platelets are small cellular fragments that are essential in molecules, leading to its uptake by phagocytes). The comple-
blood clotting, but they can also be activated during immune ment system can also be activated by antibodies bound to the
responses to release mediators of inflammation. pathogen via the ‘classical pathway’ or by mannose binding
lectin bound to the pathogen surface via the ‘lectin pathway’.
Soluble Mediators of Immunity Complement activation is a cascade reaction, where one
A wide variety of molecules are involved in the development of component acts enzymatically on the next component in the
immune responses, including antibodies, opsonins and comple- cascade to generate an enzyme, which mediates the following
ment system molecules. The serum concentration of a number step in the reaction sequence, and so on. (The blood clotting sys-
of these proteins increases rapidly during acute infection and tem also works as an enzyme cascade.)
they are therefore called acute phase proteins. Activation of the complement system generates protein mol-
One example of an acute phase protein is C-reactive protein ecules or peptide fragments, which have the following effects:
(CRP), so-called because of its ability to bind to the C protein • opsonization of microorganisms for uptake by phagocytes
of pneumococci; it promotes the uptake of pneumococci by pha- and eventual intracellular killing;
gocytes. Molecules such as CRP that promote phagocytosis are • attraction of phagocytes to sites of infection (chemotaxis);
said to act as opsonins. There are a number of these evolution- • increased blood flow to the site of activation and increased
arily ancient molecules in mammals and they recognize conserved permeability of capillaries to plasma molecules;
structures on the surface of pathogens called pathogen-associated • damage to plasma membranes on cells, Gram-negative bac-
molecular patterns (PAMPs) (see Chapter 3). Another important teria, enveloped viruses, or other organisms that have caused
group of molecules that can act as opsonins are components of complement activation;
the complement system (see Chapter 4). • release of inflammatory mediators from mast cells.
CHAPTER 1 Introduction to the Immune System 5
complement
IFN␣
IFN
virus
infected cell
virus-resistant
bacteria phagocyte bacteria T IFN␥ cell
antigen
1. lysis 2. chemotaxis 3. opsonization
Fig. 1.7 Interferons Host cells that have been infected by virus secrete
interferon-α (IFNα) and/or interferon-β (IFNβ). TH1 cells secrete interferon-
γ (IFNγ) after activation by antigens. IFNs act on other host cells to induce
resistance to viral infection. IFNγ has many other effects.
1 2 3
Fig. 1.8 Three phases in neutrophil migration across endothelium A neutrophil adheres to the endothelium
in a venule (1). It extends its pseudopodium between the endothelial cells and migrates towards the basement
membrane (2). After the neutrophil has crossed into the tissue, the endothelium reseals behind (3). The entire
process is referred to as diapedesis. (Courtesy Dr I Jovis.)
CHAPTER 1 Introduction to the Immune System 7
infected cell
MHC molecule presents
peptide
2
complement antigen peptide bound
C3b to MHC molecule
4
antibody and
complement
C3b
Fig. 1.15 T-cell recognition of antigen Major histocompatibility com-
plex (MHC) molecules transport peptides to the surface of an infected cell
Fig. 1.14 Opsonization Phagocytes have some intrinsic ability to bind to where they are presented to T cells, which may recognize the MHC–
bacteria and other microorganisms via their pattern recognition receptors peptide combination. If a cell is infected, MHC molecules present
(1). Binding is much enhanced if the bacteria have been opsonized by peptides derived from the pathogen and the cell’s own proteins.
complement C3b (2) or antibody (3), each of which cross-links the bacteria
to receptors on the phagocyte. Antibody can also activate complement,
and if antibody and C3b both opsonize the bacteria, binding is further
enhanced (4). ANTIGEN PRESENTATION
Virtually all cells of the body can present antigen to CTLs, but
there is a more limited group of specialized antigen-presenting
other circumstances, not just phagocytosis. For example, anti- cells (APCs) which process and present antigens to helper T
bodies bound to parasitic worms allow them to be recognized cells. Several different types of leukocyte can act as APCs,
by eosinophils. Another type of antibody binds to receptors including dendritic cells, macrophages and B cells. All of these
on mast cells and allows them to recognize soluble antigens cells internalize antigens from the extracellular space by
(see Chapter 10). phagocytosis or endocytosis. These APCs then display antigenic
peptide–MHC complexes on the cell surface and they express
co-stimulatory molecules that are essential for initiating
Peptides from intracellular pathogens are displayed on the immune responses. Activation of a TH cell requires both the
surface of infected cells. Antibodies are present only in extra- signal from antigenic peptide–MHC and co-stimulation.
cellular spaces, including blood, lymph and tissue fluids, and Co-stimulatory signals are upregulated by the presence of
they can usually only target extracellular pathogens. Intracellu- pathogens, which can be detected by the engagement of innate
lar pathogens (such as viruses) can escape antibody-mediated immune receptors that recognize PAMPs.
responses once they are safely located within a host cell. The Most immune responses to infectious organisms are made up
adaptive immune system has therefore evolved a specific of a variety of innate and adaptive components. In the earliest
method of displaying portions of virtually all cell proteins on stages of infection, innate responses predominate; later the lym-
the surface of each nucleated cell in the body so that they can phocytes start to generate adaptive immune responses. After
be recognized by T cells. recovery from infection, immunological memory remains
For example, a cell infected with a virus will present fragments within the population of lymphocytes, which can then mount
of viral proteins (peptides) on its surface that are recognizable by a more effective and rapid response if there is re-infection with
T cells. The antigenic peptides are transported to the cell surface the same pathogen at a later date.
and presented to the T cells by MHC molecules (a group of mol- The two major phases of any immune response are antigen
ecules encoded within the major histocompatibility complex, see recognition and a reaction to eliminate the antigen.
Chapter 6). T cells use their antigen-specific receptors (TCRs) to
recognize the antigenic peptide–MHC molecule complex Antigen activates specific clones of lymphocytes. In adap-
(Fig. 1.15). If an infected cell (target) is recognized by a cytotoxic tive immune responses, lymphocytes are responsible for
T cell (CTL), the T cell can signal to the target cell to induce immune recognition, which is achieved by clonal selection. Each
apoptosis (programmed cell death). The process by which lymphocyte is genetically programmed to produce one specific
MHC molecules facilitate recognition of antigenic peptides is antigen receptor (BCR or TCR) capable of recognizing just one
one component of a wider process called antigen presentation particular antigen. However, the immune system as a whole can
(see Chapter 7). specifically recognize many thousands of antigens and the
10 SECTION 1 The Immune System and Innate Immunity
lymphocytes that recognize any particular antigen are only a Lymphocytes that have been stimulated, by binding to their
tiny proportion of the total. specific antigen, take the first steps towards cell division. They
How then is an adequate immune response to an infectious express new receptors that allow them to respond to cytokines
agent generated? The answer is that, when an antigen binds to from other cells and will usually go through a number of cycles
the few lymphocytes that can recognize it, they are induced to of division before differentiating into mature cells, again under
proliferate rapidly. Within a few days there is a sufficient num- the influence of cytokines. They may also start to produce sets of
ber to mount an adequate immune response. In other words, the cytokines themselves.
antigen selects and activates the specific clones to which it binds Even when the infection has been overcome, some of
(Fig. 1.16), a process called clonal selection. This operates for the newly produced lymphocytes remain, available for re-
both B cells and T cells. stimulation if the antigen is ever encountered again. These cells
How can the immune system know which specific antibodies are called memory cells, because they are generated by past
will be needed during an individual’s lifetime? It does not know. encounters with particular antigens. Memory is partly the result
The immune system generates antibodies (and T-cell receptors) of the expansion of the responding population of lymphocytes
that can recognize an enormous range of antigens even before it in the first immune response and partly because these cells are
encounters them. Many of these specificities, which are gener- more easily activated on subsequent encounters with the anti-
ated more or less at random, will never be called upon to protect gen. Memory cells confer lasting immunity to a particular
the individual against infection. pathogen.
What is the advantage of generating billions of lymphocytes
that do not recognize any known infectious agent? Many path-
ogens mutate their surface antigens. Indeed the immune system ANTIGEN ELIMINATION
provides selective pressure for the evolution of new strains of
pathogen with altered antigens. If the immune system could There are numerous ways in which the immune system can
destroy pathogens, each being suited to a given type of infection
not recognize new variants of pathogens, it would not be able
at a particular stage of its life cycle. These defence mechanisms
to make an effective immune response. By having a wide range
are often referred to as effector systems.
of antigen receptors, at least some of the lymphocytes will be
able to recognize any pathogen that enters the body.
Antibodies can directly neutralize some pathogens. In one of
the simplest effector systems, antibodies can combat certain
antigen selection
pathogens just by binding to them. For example, antibody to
the outer coat proteins of some rhinoviruses (which cause colds)
can prevent the viral particles from binding to and infecting
host cells.
BCR
Pelecanus bassanus, Linn. Nat. vol. i. p. 217.—Lath. Ind. Ornith. vol. ii. p.
891.
Sula bassana, Ch. Bonaparte, Synopsis of Birds of United States, p. 408.
Gannet, Nuttall, Manual, vol. ii. p. 495.
An adult Male killed near Boston. The cellular tissue of the back
exhibits vacuities of very large size, intervening between the skin
and the muscles: one, at the lower part of the neck behind, being 5
inches in length; another 5 1/2 inches long, extending from the
furcula down the humerus; and behind the wings four others,
extending to the last rib. Branches from these pass between the
muscles, which present the appearance of having been as it were
dissected. A cell of enormous size covers the side of the abdomen,
and another pair run down the middle of it, separated by a partition in
the median line. That part of the cellular tissue which adheres to the
bases of the feathers is also remarkably loose; and, close to each of
them, is a roundish aperture of large size, communicating with the
great cavities mentioned above. Between the pectoralis major and
the subjacent muscles is a large interspace formed by a great cell.
The internal thoracic and abdominal cells are also very large.
On the roof of the mouth are five sharp ridges. The nasal aperture is
1 inch and 5 twelfths long, linear, with a soft longitudinal flap on each
side. The tongue is extremely small, being only 7 twelfths long, 1
twelfth broad, blunt at the extremity, and with two papillae at the
base. The bare skin between the crura of the mandibles is of the
same structure as that of the Pelicans and Cormorants, but of small
extent, its posterior acute extremity not extending farther than that at
the base of the bill. The aperture of the glottis is 7 1/2 twelfths long.
The thyroid bone has an anterior curved prolongation, which projects
forwards, and from the extremity of which comes the elastic ligament
by which it is connected with the hyoid bone. The œsophagus, a, b,
is 15 inches long, measured to the commencement of the
proventriculus, extremely dilated, its diameter 2 1/2 inches at the top,
contracting to 2 inches as it enters the thorax, its narrowest part 1
inch 4 twelfths; its transverse muscular fibres moderately strong. The
proventriculus, c, d, is excessively large, 3 1/2 inches long, its
greatest diameter 2 1/4 inches. The glandules are cylindrical, 3
twelfths long, forming a very broad belt, separated however at its
narrowest part by a longitudinal interval of 5 twelfths of an inch, and
having three partial divisions on its lower edge. The greatest length
of the proventriculus, or breadth of the belt of glandules, is 2 1/2
inches. The mucous coat of the œsophagus is smooth, but thrown
into longitudinal plicæ when contracted; that of the proventriculus is
continuous, and of the same nature, being marked with extremely
minute reticulated lines, of which the more prominent have a
longitudinal direction. The stomach, properly so called, d e, is
extremely small, being only 1 inch 9 twelfths long, and about the
same breadth. Its inner coat is similar to that of the œsophagus and
proventriculus; being destitute of epithelium; several large mucous
crypts are scattered over its surface. The pylorus is small, having a
diameter of nearly 3 twelfths, and a marginal flap or valve on one
side. The intestine, f, g, h, is of moderate length, measuring 53
inches. The duodenum at first passes upwards in the direction of the
liver for 2 inches, f g, is then recurved for 3 inches, g, h, ascends for
4 inches, h, i, and receives the biliary ducts, then passes toward the
spine and forms a curvature. The average diameter of the intestine is
5 twelfths at the upper part, and it gradually contracts to 3 twelfths.
The rectum, k, measured to the anus is 5 1/4 inches. It gradually
enlarges from 4 to 6 1/2 twelfths. The cloaca, m, is globular, 9
twelfths long, 8 twelfths broad. The cœca are 3 twelfths long, 1 1/2
twelfth broad.
The lobes of the liver are extremely unequal, as is always the case
when the stomach or the proventriculus is excessively large, the right
lobe being 2 3/4 inches long, the left 1 inch and 8 twelfths. The gall-
bladder, n, is very large, of an oblong form, rounded at both ends, 1
inch and 8 twelfths long.
The trachea is 12 inches long, moderately ossified, round, its
diameter at the top 7 twelfths, gradually narrowing to 4 twelfths; the
rings 124, the lower 4 united, The bronchi are large, their diameter
greater than that of the lower part of the trachea; of 25 cartilaginous
half-rings. The lateral or contractor muscles of the trachea are of
moderate strength; the sterno-tracheals strong; a pair of inferior
laryngeal muscles attached to the glandular-looking, yellowish-white
bodies inserted upon the membrane between the first and second
rings of the bronchi.
The olfactory nerve comes off from the extreme anterior point of the
cerebrum, enters a canal in the spongy tissue of the bone, and runs
in it close to the septum between the eyes for 10 twelfths of an inch,
with a slight curve. It then enters the nasal cavity, which is of an
irregular triangular form, 1 1/2 inch long at the external or palatal
aperture, 10 twelfths in height. The supramaxillary branch of the fifth
pair runs along the upper edge of the orbit, and by a canal in the
spongy tissue of the bones, enters the great cavity of the upper
mandible, keeping nearer its lower surface, and there branching.
This cavity appears to have no communication with the nasal; nor
has the latter any passage towards the obliterated external nostrils.
The lachrymal duct passes obliquely inwards from the anterior
corner of the eye, and enters the nasal cavity by an aperture 1/2
twelfth in diameter, near its anterior margin.
In the cloaca was found a solid calculus, half an inch in diameter, of
an irregular form, white within, externally pale yellowish-brown, and
marked with grooves impressed by the action of the sphincter ani.
The digestive and respiratory organs of the American Gannet are
thus precisely similar to those of the European. In external form,
proportions, and colours, there are no appreciable differences. The